On November 22, FDA released the new draft guidance for “Transdermal and Topical Delivery Systems (TDS) – Product Development and Quality Considerations”. This is a useful guide to help the industry to deal with the complexity of the transdermal delivery system or patch and the associated challenges related to product development.